Theme: Glycobiology:The Bitter Side of Sweet World

Glycobiology 2016

Renowned Speakers

Glycobiology 2016

 

Conference Series LLC feels great to invite you all to attend “2nd Glycobiology World Congress (Glycobiology-2016)” which is going to be held during August 29-31, 2016 at Atlanta, USA on a theme “Glycobiology: The Bitter Side of Sweet World”. Glycobiology-2016 welcomes biochemists, researchers, molecular biologists, industry experts, delegates, sponsors and exhibitors from all over the world to the extraordinary splendid city of Atlanta, USA.

Conference Series LLC Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Global glycobiology market was valued at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019).

Join us in Atlanta and experience the World's Greatest Biochemist Scientist Meet.

Conference Series LLC invites all the participants across the globe to attend the 2nd Glycobiology World Congress (Glycobiology -2016) during August 29-312016 at Atlanta, USA.

The conference was marked with the attendance of Editorial Board Members, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive. Glycobiology-2016 mainly concentrates on Role of glycans and there Infectious Diseases, amalgamating the branches of Biochemistry where the specialization deals with the diagnosis and treatment of Diseases and its related fields. Glycobiology -2016  hosted  by  OMICS Group Meetings which is  a three day event consisting of a scientific program , comprehensive talks, special sessions, oral & poster presentations of peer-reviewed contributed papers and exciting and innovative research products which can be exhibited for the further development of Glycobiology. We provide a platform where you can exchange your knowledge and experiences with the developing trends in the related fields of Glycobiology. Glycobiology -2016 will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Glycobiology field across the world. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies on Glycobiology-2016.

Glycobiology conference -2016 is designed to meet all renowned and eminent speakers from all around the globe with delegates, exhibitors, industry experts and work shop symposiums.

For more details: http://glycobiology.conferenceseries.com/

Scientific Sessions:

Track: 1 Glycans in Diseases and Therapeutics

The beginning of the 20(th) century marked the dawn of modern medicine with glycan-based therapies at the forefront. However, glycans quickly became overshadowed as DNA- and protein-focused treatments became readily accessible. The recent development of new tools and techniques to study and produce structurally defined carbohydrates has spurred renewed interest in the therapeutic applications of glycans. Glycan Analysis review focuses on advances within the past decade that are bringing glycan-based treatments back to the forefront of medicine and the technologies that are driving these efforts. These include the use of glycans themselves as therapeutic molecules as well as engineering protein and cell surface glycans to suit clinical applications to that of databases providing glycoenzyme data. Glycoconjugates offer a rich and promising frontier for developments in the academic, biopharmaceutical, and medical fields.

Martin Dalziel and their colleagues at Oxford University learned about glycans in the context of pathogen invasion, cancer and autoimmunity, and congenital diseases. Biota, GlaxoSmithKline, Gilead and Roche are the companies mainly focusing research on glycans section of diseases and its therapeutic applications. The Company’s ultimate goal is to bring to market promising novel classes of therapeutic agents, functional foods, and diagnostics based on the naturally occurring bioactive glycans.

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 2 Glycobiology: It’s Role in Human Health

Glycobiology and Glycochemistry are the two main intertwined areas of Glycosciences, dealing with various aspects of glycans, including carbohydrate structure, biochemistry, biological functions and applications. This is necessary in order to sustain and advance the identification of key glycobiological aspects and the application of glycans and glycoengineering strategies in the design of novel therapies to improve human health. The glycans (carbohydrates) form a diverse group of biomolecules which play active parts in most physiological processes. The field of structural glycobiology concerns the structures of the glycans themselves, the proteins which interact with them and the nature of the interactions between the two. Drug targeting is important for our understanding of human health and disease, and for development of new therapeutic strategies.

Researchers at the University of Georgia have received a five-year, $10.4 million grant from the National Institutes of Health to support the National Center for Biomedical Glycomics, a consortium of UGA faculty and staff working to develop new technologies for the analysis of glycans, Scientists now recognize that glycans play critical roles in cell regulation, human health and disease progression. The experts at the Complex Carbohydrate Research Center have experience and knowledge that make us a world leader in this field, and are creating technologies and tools that are the foundation for the next generation of diagnostics and treatments.

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 3 Glycobiology & Biotechnology

Glycans are components of many biotherapeutic agents, ranging from natural products to molecules based on rational design to recombinant glycoproteins. The glycan components of these agents can be important determinants of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology involves a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids  and some other plant proteins that are capable of interacting with endogenous or foreign (macro) molecules. The emphasis of the research is on protein-carbohydrate interaction and their involvement in signalling processes in plants or in plant protection. Based on the generated fundamental knowledge novel strategies are being developed to protect crop plants against pests and diseases.

The key drivers for this glycobiology market are the rising R&D expenditure by pharmaceutical and biotech companies, and increasing public and private funding for proteomics and glycobiology research. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the glycobiology enzymes, instruments, kits, and reagents market.

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 4 Glycomics and Bioinformatics

Glycomics the scientific attempt to characterize and study carbohydrates, is a rapidly emerging branch of science, for which informatics is just beginning. Glycomics requires sophisticated algorithmic approaches. Several algorithms and models have been developed for glycobiology research in the past several years. The development and use of informatics tools and databases for glycobiology and glycomics research has increased considerably in recent years. However, the general development in this field can still be considered as being in its infancy when compared to the genomics and proteomics areas. In terms of bioinformatics in glycobiology, there are several paths of research that are currently in progress. The development of algorithms and software tools for interpretation of glycans to reliably support the characterization of glycan structures for high-throughput applications is the most immediate demand of the glycomics community.

The global glycomics market was valued at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019).

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 5 Classification of Glycan Binding Proteins

Glycans can mediate a wide variety of biological roles by virtue of their mass, shape, charge, or other physical properties. However, many of their more specific biological roles are mediated via recognition by GBPs. Nature appears to have taken full advantage of the vast diversity of glycans expressed in organisms by evolving protein modules to recognize discrete glycans that mediate specific physiological or pathological processes. Excluding glycan-specific antibodies, GBPs broadly into two major groups such as lectins and glycosaminoglycan-binding proteins. Most lectins are members of families with defined “carbohydrate-recognition domains” (CRDs) that apparently evolved from shared ancestral genes, often retaining specific features of primary amino acid sequence or three-dimensional structure. Thus, new family members can be identified by searching protein sequence or structural databases. The natural ligands for most lectins are typically complex glycoconjugates that carry clustered arrays of the cognate carbohydrate or unique glycan structures, thus cooperating with clustered lectin-binding sites to generate high-avidity binding, which is further enhanced by mass transport effects (high local concentrations of ligands).

Paulson group investigates the roles of glycan binding proteins that mediate cellular processes central to immune regulation and human disease. Their work includes at the interface of biology and chemistry to understand how the interaction of glycan binding proteins with their ligands mediates cell-cell interactions, endocytosis and cell signaling. Their multi-disciplinary approach is complemented by a diverse group of chemists, biochemists, cell biologists, and molecular biologists.

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 6 Synthesis and Biological Role of Glycans

As with other major classes of macromolecules, the biological roles of glycans span the spectrum from those that appear to be relatively subtle, to those that are crucial for the development, growth, functioning, or survival of the organism that synthesizes them. The biological roles of glycans can be divided into two broad categories: (1) the structural and modulatory properties of glycans and (2) the specific recognition of glycans by other molecules most commonly, glycan-binding proteins (GBPs). The biological consequences of altering glycosylation in various systems seem to be highly variable and unpredictable. A given glycan can have different roles in different tissues or at different times in development (organism-intrinsic functions) or in different environmental contexts (organism-extrinsic functions). Approaches taken to understand the biological roles of glycans include the prevention of initial glycosylation, prevention of glycan chain elongation, alteration of glycan processing, enzymatic or chemical deglycosylation of completed chains, genetic elimination of glycosylation sites, and the study of naturally occurring genetic variants and mutants in glycosylation. Glycosylation mainly refers in particular to the enzymatic process that attaches glycans to proteins, lipids, or other organic molecules. This enzymatic process produces one of the fundamental biopolymers found in cells (along with DNA, RNA, and proteins). Glycosylation also plays a role in cell-cell adhesion (a mechanism employed by cells of the immune system) via sugar-binding proteins called lectins, which recognize specific carbohydrate moieties.

Nucleic acids, proteins, lipids, and glycans are the four classes of biomolecules that define life. Recent advances in life science research have painted a very different point of view of the importance of these quintessential biomolecules. Even though our knowledge is still limited, glycans are becoming more important to other fields such as vaccines, therapeutics, diagnostics, materials, and energy. This will subsequently speed up the advancement in other fields, such as research on carbohydrate-based vaccines that require access to well-defined carbohydrate structures and tools.

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 7 Evolution of Glycan Diversity

Glycans are saccharides that can be attached to a wide variety of biological molecules through an enzymatic process called glycosylation to augment their function. Of the four fundamental building blocks of life, proteins, carbohydrates (glycans), lipids and nucleic acids, glycans have received the least attention from researchers. Glycans are found in archaea, bacteria and eukaryotes, and their diverse functions contribute to physical and structural integrity, extracellular matrix formation, signal transduction, protein folding and information exchange between cells (and pathogens). Glycans are the predominant molecule on the cell surface and serve as the first point of contact between a cell and other cells, the extracellular matrix and pathogens. The heightened evolutionary pressure of being at the front lines of cellular collaboration and conflict most likely led to the diversification of glycans. Glyco-epitope diversity enhances the role of glycans in the group of debilitating and life-shortening disorders known as congenital muscular dystrophy, or CMD. Both membrane proteins and the ECM are highly glycosylated, and O-glycans are essential for proper ECM function and communication between cells and the ECM. Several Glycoepitomics forms of CMD are known to result from dysfunctional O-glycosylation of membrane and ECM proteins; however, one-third of CMDs arise from an unknown genetic etiology.

Glycosylation is a critical function of the biosynthetic-secretory pathway in the endoplasmic reticulum (ER) and Golgi apparatus. Glycosylation increases the diversity of the proteome to a level unmatched by any other post-translational modification. Glycosidases catalyze the hydrolysis of glycosidic bonds to remove sugars from proteins. These enzymes are critical for glycan processing in the ER and Golgi, and each enzyme shows specificity for removing a particular sugar (e.g., mannosidase).

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 8 Glycan Catabolism and Systemic Physiology

The human gut hosts trillions of bacteria that directly influence human health. The majority of gut microbiota play an important role in nutrition by metabolizing host-indigestible complex glycans into short-chain fatty acids. Growth of the mesh-like peptidoglycan (PG) sacculus located between the bacterial inner and outer membranes (OM) is tightly regulated to ensure cellular integrity, maintain cell shape, and orchestrate division. Cytoskeletal elements direct placement and activity of PG synthases from inside the cell, but precise spatiotemporal control over this process is poorly understood. Glycan catabolism contains metabolic pathway maps for glycans. Some of them contain an alternative representation of glycan biosynthesis or degradation, called the glycan structure map.

Asparagine (N)-linked protein glycosylation is a ubiquitous co- and post-translational modification which can alter the biological function of proteins and consequently affects the development, growth, and physiology of organisms. In mammals, complex N-glycans are involved in different cellular processes including molecular recognition and signaling events.

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 9 Glyco Immunology

Carbohydrates were prominent in the early history of immunology in defining the identity of antigens recognized by antibodies. In addition, the ability of antibodies to specifically recognize glycans was exploited in studies defining the size of the antigen-binding site. Nevertheless, for many decades following these early discoveries the broader potential importance of carbohydrates in both innate and adaptive immune responses was largely overlooked. However, times are changing and glycobiologists and immunologists are now collaborating extensively to explore this very fertile area of immunobiologyNumerous carbohydrate-binding proteins, or lectins, have been identified on the surfaces of immune cells. Interactions of lectins with glycans usually require several monosaccharide moieties presented in the correct conformation for high-affinity binding. Modification of proteins and lipids by glycosylation is a highly regulated process resulting in a diverse repertoire of glycan structures.

Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 10 Glycans in Drug Design

Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019).

Relevant Conferences:

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy Valencia, Spain; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

2nd Glycobiology World Congress

(Theme: Glycobiology: The Bitter Side of Sweet World)

About the Conference:

Glycobiology-2016 welcomes attendees, presenters, and exhibitors from all over the world to Atlanta, USA. We are delighted to invite you all to attend and register for the “2nd Glycobiology World Congress (Glycobiology-2016)” which is going to be held during August 29-31, 2016 in Atlanta, USA.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Glycobiology-2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Glycobiology-2016 organizing committee look forward to meeting you in Atlanta, USA.

For more details please visit- http://glycobiology.conferenceseries.com/index.php

Importance & Scope:

      Most aspects of Glycobiology depend on successful researches. Glycobiology is a process to a new innovation, a new era. Glycobiology-2016 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Glycobiology leading way to the unraveled. It also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Glycobiology.

Glycobiology-2016 is a quint essential platform for presenting research about marketing, exchanging ideas about it and thus, contributes to the dissemination of knowledge for the benefit of both the academia and business. Glycobiology is where the future intersects. This event brings together eminent researchers and associates to explore the emerging field. We bring together Knowledge, creative, and technology leaders from the Biology industry for the most current and relevant discussions.

Why Atlanta?

     Atlanta is the capital of and the most populous city in the US state of Georgia, with an estimated 2013 population of 447,841. Atlanta is the cultural and economic center of the Atlanta metropolitan area, home to 5,522,942 people and the ninth largest metropolitan area in the United States. Atlanta is the county seat of Fulton County, and a small portion of the city extends eastward into DeKalb County.

Atlanta was established in 1837 at the intersection of two railroad lines, and the city rose from the ashes of the Civil War to become a national center of commerce. In the decades following the Civil Rights Movement, during which the city earned a reputation as "too busy to hate" for the progressive views of its citizens and leaders, Atlanta attained international prominence. Atlanta is the primary transportation hub of the Southeastern United States, via highway, railroad, and air, with Hartsfield–Jackson Atlanta International Airport being the world's busiest airport since 1998.

Atlanta is considered an "alpha-" or "world city", ranking 15th among world cities and sixth in the nation with a gross domestic product of $270 billion. Atlanta's economy is considered diverse with dominant sectors including logistics, professional and business services, media operations, and information technology. Topographically, Atlanta is marked by rolling hills and dense tree coverage. Revitalization of Atlanta's neighborhoods, initially spurred by the 1996 Olympics, has intensified in the 21st century, altering the city's demographics, politics, and culture.

   Glycobiology Market Global Forecast to 2019: The Glycobiology market will reach $928.11 million by 2019, growing at a CAGR of 12.62% during the forecast period (2014–2019). This report segment the global Glycobiology market by application, end users, products, and geographies. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the Glycobiology enzymes, instruments, kits, and reagents market. A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global Glycobiology enzymes. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. [Source: Ref3]

Conference Highlights:

·         Glycans in Diseases and Therapeutics

·         Glycobiology: Its Role In Human Health

·         Glycobiology & Biotechnology

·         Glycomics and Bioinformatics

·         Classification of Glycan Binding Proteins

·         Synthesis and Biological Role of Glycans

·         Evolution of Glycan Diversity

·         Glycan Catabolism and Systemic Physiology

·         Glyco Immunology

Why to attend???

MEET YOUR TARGET MARKET with members from around the world focused on learning about Biological research and growing market, this is your single best opportunity to reach the largest assemblage of participants from the scientific community. Conduct demonstrations, distribute information, meet with current and potential customers, and make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Glycobiology growing market are hallmarks of this conference.

Be Part of it!

• This conference focusing on all the major aspects in the fields of Glycobiology.

• It would be beneficial for all the students who ever willing to enter into research to the respective fields.

• As bringing the major research to the market and making it to utility are major focus for all the companies, this conference would be opportunity for the people in the respective fields.

 A Unique Opportunity for Advertisers and Sponsors at this International event:                                            

http://omicsgroup.com/conferences/ACS/conference/pdfs/glycobiology2016_Sponsorship.pdf

Major Glycobiology Associations around the Globe

    Glyconet Glycobiotechnology Network

    Glycoscience Graduate School

    Mizutani Foundation for Glycoscience

    The Japanese Society of Carbohydrate Research

    Alberta Glycomics Centre

    Copenhagen Center for Glycomics

    CKSP: Center of Know-how for Sugars and Polysaccharides, Ben-Gurion University

    Laboratory of Carbohydrate Chemistry, Institute of Bioorganic Chemistry, Russian Academy         of Science

    Glycoprotein Structure/Function Group, Birkbeck College

    Oxford Glycobiology Institute

    Centre for Glycobiology, University of Liverpool

    IBS: Institut de Biologie Structurale

    Glycoscience Team, National Centre for Biomedical Engineering Science, National University        of Ireland, Galway

Major Glycobiology Related Associations in Atlanta

Glycotechnology Core Resource

Glycobiology Research and Training Center

Glycomics Center

Heparin Home Page, Rensselaer Polytechnic Institute

OCMG: Oklahoma Center for Medical Glycobiology

Resource for Integrated Glycotechnology

The Carbohydrate Section, National Institute of Diabetes and Digestive and Kidney Diseases

The Scripps Research Institute

Whistler Center for Carbohydrate Research

Institute of Molecular Biomembrane and Glycobiology

Target Audience:

Directors/Managers & Business Delegates,  Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students and Biomedical Research companies.  

Academia      60%

Industry        30%

Others           10%

Top Universities:

There are around 100 plus universities in Georgia State and according to Georgia regional report top universities in Georgia number 18 out of which 5-8 universities are involved in glycobiology related research.

Glance at Market of Glycobiology:

The technological progress in biochemistry and molecular biology has played a significant role in the development of the glycobiology market during the last decade. Also, the improvements in analytical instruments, and data processing and analysis software have contributed significantly in the advancement of the glycobiology field. The presence of research funding and government support for conducting research and commercialization of the products in the glycobiology market is the primary driver for the growth of this market. Glycobiology science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the glycobiology market.

The global glycomics market was valued at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019). Geographic analysis reveals that North America accounted for the largest share of the global glycomics market in 2014, due to increasing funding for proteomics and glycomics research. For instance, in August 2013, the National Institutes of Health (NIH) provided $5.5 million to the National Center for Functional Glycomics (NCFG) for research into the identification of glycans and complex carbohydrates using glycan microarrays. Similarly, in 2011, the University Of Nevada School Of Medicine received $10 million for glycobiology research from NIH. [Source: Ref2]

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S). [Source: Ref1]

References:

1.      http://www.whatech.com/market-research-reports/press-release/medical/32147-worldwide-glycobiology-market-grow-at-a-cagr-of-12-62-to-reach-928-11-million-by-2019

2.      http://www.marketsandmarkets.com/PressReleases/glycobiology.asp

3.      http://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html

4.     http://www.glyco.ac.ru/worldglycoscience.html

5.      http://www.glycoforum.gr.jp/square/newsE.html

 

 

 

Glycobiology 2015

Glycobiology World Congress (Glycobiology-2015) was held during August 10-12, 2015 at DoubleTree by Hilton Philadelphia Airport Hotel, USA. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 30 countries, who made this conference fruitful and productive.

This conference was based on the theme “Transforming Glycobiology: A Road map for the Future” which included the following scientific tracks: 

·         Synthesis and Biological Role of Glycans

·         Evolution of Glycan Diversity

·         Discovery and Classification of Glycan Binding Proteins

·         Glycan Catabolism and Systemic Physiology

·         Glycans in Diseases and Therapeutics

·         Glycomics and Bioinformatics

·         Glycobiology: Its Role In Human Health

·         Glyco Immunology

Glycobiology-2015 Organizing Committee would like to thank the moderators Dr. Neil P.J. Price from National Center for Agricultural Utilization Research, USA and Myron R Szewczuk from Queen’s University, Canada.

We are thankful to our below Honourable guests and Keynote Speakers for their generous support and suggestions.

Michael P Jennings – Griffith University, Australia

Joseph J Barchi Jr - National Cancer Institute, USA

Neil P.J. Price - National Center for Agricultural Utilization Research, USA

Myron R Szewczuk - Queen’s University, Canada

Konrad Sandhoff - LIMES Institut, Germany

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

·Application of Glycan array analysis in the discovery of novel bacterial; host interactions:  Michael P Jennings, Griffith University, Australia

· Glycopeptide conjugates of a specific tumor associated carbohydrate antigen as anticancer agen: Joseph J Barchi Jr, National Cancer Institute, USA

Tunicamycins: translocase-I inhibitors that target bacterial cell wall and mammalian N-glycoproteins. The potential for selective inhibitors: Neil P.J. Price, National Center for Agricultural Utilization Research, USA

Role of glycosylation in TOLL-like receptor activation and pro-inflammatory responses- Myron R Szewczuk, Queen’s University, Canada

Membrane lipids regulate glyco sphingolipid catabolism, their enzymes and lipid binding proteins: Konrad Sandhoff, LIMES Institut, Germany

NaH Inhibits β-Amyloid Fibril Formation in Alzheimer’s disease Rats: Maria O. Longas, Purdue University, USA

Influence of glycans on biological activities of pituitary gonadotropins, follicle stimulating hormone and luteinizing hormone: George R. Bousfield, Wichita State University, USA

Various sessions were chaired and co-chaired by: Joseph J Barchi Jr, National Cancer Institute, USA, Neil P. Price, National Center for Agricultural Utilization Research, USA, Myron R Szewczuk, Queen’s University, Canada, Konrad Sandhoff, LIMES Institut, Germany, and Barbara Klajnert-Maculewicz, University of Lodz, Poland·       

 Poster Session was judged by Neil P.J. Price – National Center for Agricultural Utilization Research, USA

OMICS International has taken the privilege of felicitating Glycobiology-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Glycobiology-2015. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Glycobiology as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, OMICS Group would like to announce the commencement of the “2nd Glycobiology World Congress" to be held during August 29-31, 2016 at AtlantaUSA.

Let us meet again @ Glycobiology-2016

 


Past Reports  Gallery  

Diabetic Medications-2015

The International Conference on Targeting Diabetes and Novel Therapeutics (Diabetic Medications-2015) convoked by OMICS International during September 14-16, 2015 was successfully held at Embassy suites Las Vegas, Nevada, USA with a theme “New insights in prevention and management of diabetes through intervening technologies” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

The pragmatic meet organized by OMICS International brought together a group of Diabetologists, Endocrinologists Clinicians, Young Researchers and Industry Representatives from across the globe with interest and expertise in the field of diabetes research. The conference marked the successful gathering of eminent speakers from various reputed organizations driving the three day event into the path of success and their regnant talks enlightened the gathering.

Diabetic Medications-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Fawad Javed, University of Rochester, USA who contributed a lot for the smooth functioning of this event.

Our special thanks to Dr. Osman Amine El-Labban, Al Zahra Private Hospital, UAE, for his special participation in the workshop titled “Role of a Preventive National Program in Combating Diabetes Mellitus & Cardiovascular Diseases” which marked the special attraction at the conference.

Diabetic Medications-2015 extends its warm gratitude to all the Honorable Guests and Keynote Speakers of the event:

Dr. Patrick G Sullivan, University of Kentucky, USA

Dr. Fawad Javed, University of Rochester, USA

Dr. Anil K Mandal, University of Florida, USA

Dr. Maria Faresjo, Jonkoping University, Sweden

Dr. Christain Dani, French National Institute for Health and Medical Research, France

Dr. Osman Amine El-Labban, Al Zahra Private Hospital, UAE

Dr. Khalid Alnemer, AL-Imam University, Kingdom of Saudi Arabia

Dr. Mohamed El-Far, Mansoura University, Egypt

Diabetic Medications-2015 conference congratulates the Best Poster Awardee Mr. Parth Rajput, Nirma University, India for his outstanding performance and appreciates all the participants who put their research at poster presentations and sincerely wish them every success in their future endeavors. Also, we would like to thank the Poster Competition Judge Dr. Emmanuel Mukwevho, North West University, South Africa for his valuable support and advice.
 

OMICS International is privileged to felicitate Diabetic Medications-2015 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. OMICS International would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Diabetes.


Past Reports  Gallery  

Integrative Biology 2015

rd International Conference on Integrative Biology was held during August 04-06, 2015 at Melia Valencia, Valencia, Spain. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Discovering, Innovating and Engineering Future Science” which included the following scientific tracks:  

  • Genomics and Bioinformatics
  • Integrative Computational Biology
  • Drug Discovery and Integrative Biology  
  • Cell Biology  
  • Tissue Biology
  • Developmental Biology
  • Bio-Engineering
  • Systems Toxicology
  • Ecology and Evolution
  • Systems Biology

Integrative Biology-2015 was moderated by Dr. Jacqueline M. Dresch (Clark University, USA) on the first and second day and by Dr. Andreia Antoniolli (Federal University of Mato Grosso do Sul, Brazil) on the third day.

We are thankful to our below Honourable guests for their generous support and suggestions.

  • Emmanuel Mic. Drakakis- Imperial College London, UK
  • Peter L. Nagy– Columbia University, USA
  • Armando del Rio Hernandez - Imperial College London, UK
  • Dang Duong Bang- Technical University of Denmark, Denmark
  • Mahmoud Rouabhia- Laval University, Canada

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

  • Ultra low power cytomimetic VLSI circuits: Synthesis method & proof-of-concept results: Emmanuel Mic. Drakakis - Imperial College London, UK
  • Integration of next-generation sequencing data with analytical chemistry, structural biology and cell biologyPeter L. Nagy – Columbia University, USA 

Various sessions were chaired and co chaired by: Jeffrey Zheng, Yunnan University, China, Anja Nohe, University of Delaware, USA, Robert A. Drewell, Clark University, USA,Armando del Rio Hernandez, Imperial College London, UK, Mahmoud Rouabhia, Laval University, Canada and Dang Duong Bang, Technical University of Denmark, Denmark,Nirmal K Shetty, Shri Krishna Research Centre, India, Jacqueline M. Dresch, Clark University, USA, Witold Chmielewski, Laval University, Canada.

OMICS Group has taken the privilege of felicitating Integrative Biology-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Integrative Biology-2015. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Biological Systems: Open Access as a special issue.


Past Reports  Proceedings  Gallery  

Obesity-2014

The 3rd International Conference and Exhibition on Obesity & Weight Management(Obesity-2014) took place at the hotel Double DoubleTree by Hilton Hotel San Francisco Airport, SF, USA from December 01-03, 2014 which was organized and hosted by the OMICS Group Conferences.

This efficacious global event featured 80% participants from over 50 different countries and remains to be the biggest international learning conference which was accomplished by the support of diabetes specialty physicians, certified dieticians, registered nurses, public health workers, fitness experts, researchers, industrial professions, CEO’s and many more delegates who spread their support to make this meeting a successful one and given additional confidence to organize our next 2015 event “ 4th International Conference and Exhibition on Obesity and Weight Management” December 07-09, 2015 Atlanta, USA

The Conference aimed: 

• To Place Obesity high on the Public Health Agendas
• To Raise Greater Awareness and High-Level Action
• To Sponsor International and Intersectoral Collaborations.


Under the overall theme of Dietary Interventions and Potential Applications to Tackle Obesity, Obesity-2014 discussed how to fight against this condition and all other preventive measures for more inclusive future which enables everyone to improve & enrich themselves.

A wide range of experts like Dr. Reza Hakkak from University of Arkansas for Medical Sciences, USA, Anil K Mandal, University of Florida, USA, Jenny E Gunton University of Sydney, Australia & M A L Fobi International Federation for Surgery of Obesity and Metabolic Disorders, USA chaired and spoke in pre-conference workshops, plenary sessions and parallel sessions where they deliberated and presented the latest information and findings in the field of Medicine.

OMICS Group has taken the honor of felicitating Obesity-2014 Organizing Committee, Editorial Board Members, Keynote Speakers, Chair persons, Poster presenters and business delegates who supported for the success of this event. We would like to convey a warm gratitude to our Media partners, Exhibitors, Supporting partners like SMOK Travels, Arkray for their participation and their timely responses.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 29-31, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations